Charles L Howe Selected Research

Charles L Howe Research Topics

Disease

11	Infections 01/2022 - 01/2003
9	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 11/2002
6	Multiple Sclerosis 01/2022 - 11/2002
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 10/2008
5	Neoplasms (Cancer) 11/2021 - 12/2008
4	Neuroinflammatory Diseases 01/2022 - 01/2016
3	Epilepsy (Aura) 12/2021 - 01/2017
3	Inflammation (Inflammations) 11/2020 - 11/2002
2	Epileptic Syndromes 01/2019 - 12/2016
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 12/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2017
2	Picornaviridae Infections 01/2016 - 08/2009
2	Central Nervous System Infections (Central Nervous System Infection) 11/2003 - 01/2003
1	Seizures (Absence Seizure) 01/2022
1	Glioma (Gliomas) 12/2021
1	Nervous System Paraneoplastic Syndromes 11/2020
1	Testicular Germ Cell Tumor 11/2020
1	Granuloma 11/2020
1	Atherosclerosis 01/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Hydrocephalus (Hydrocephaly) 01/2017
1	Viral Encephalitis 01/2016
1	Guillain-Barre Syndrome 04/2013
1	Leukemia 11/2011
1	Brain Neoplasms (Brain Tumor) 11/2011
1	Edema (Dropsy) 10/2008
1	Encephalomyelitis (Myeloencephalitis) 04/2008
1	Encephalitis (Encephalitis, Rasmussen) 02/2007
1	Asthma (Bronchial Asthma) 11/2006
1	Stroke (Strokes) 02/2004
1	Alzheimer Disease (Alzheimer's Disease) 02/2004
1	Down Syndrome (Down's Syndrome) 01/2004
1	Neuroblastoma 01/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2002

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin G (IgG)IBA 01/2022 - 10/2008
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2008
4	CytokinesIBA 01/2022 - 11/2002
4	Complement System Proteins (Complement)IBA 01/2022 - 10/2008
4	AutoantibodiesIBA 01/2019 - 02/2004
4	Immunoglobulin M (IgM)IBA 01/2019 - 10/2003
3	Aquaporins (Water Channels)IBA 01/2022 - 09/2015
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019 - 12/2016
2	PerforinIBA 09/2009 - 02/2007
2	Antiviral Agents (Antivirals)IBA 08/2009 - 08/2007
1	Kainic Acid (Kainate)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	teriflunomideIBA 01/2022
1	CuprizoneIBA 12/2021
1	GadoliniumIBA 11/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Ritonavir (Norvir)FDA Link 01/2016
1	CalpainIBA 01/2016
1	ParaffinIBA 09/2015
1	Immunoglobulins (Immunoglobulin)IBA 09/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2013
1	Therapeutic UsesIBA 11/2011
1	Isoflurane FDA LinkGeneric 06/2011
1	Caspase 3 (Caspase-3)IBA 08/2009
1	ChromatinIBA 08/2009
1	3,3',4,5'-tetrahydroxystilbeneIBA 12/2008
1	Glutamic Acid (Glutamate)FDA Link 10/2008
1	LigandsIBA 05/2008
1	Neutralizing AntibodiesIBA 04/2008
1	HLA-DR Antigens (HLA-DR)IBA 04/2008
1	Peptides (Polypeptides)IBA 08/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2007
1	Nerve Growth Factor (NGF)IBA 01/2004
1	Interferon-gamma (Interferon, gamma)IBA 11/2003
1	Monoclonal AntibodiesIBA 10/2003
1	CalciumIBA 10/2003
1	ChemokinesIBA 01/2003
1	Neuroprotective AgentsIBA 01/2003
1	Interleukin-6 (Interleukin 6)IBA 01/2003
1	InterleukinsIBA 11/2002
1	Nerve Growth Factors (Neurotrophins)IBA 11/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2002

Therapy/Procedure

1	Immunotherapy 11/2020
1	Cranial Irradiation 11/2011
1	Therapeutics 09/2006